BioPharma Credit PLC (BOPCF)
OTCMKTS · Delayed Price · Currency is USD
0.8364
-0.0998 (-10.66%)
Jul 1, 2025, 3:24 PM EDT

BioPharma Credit Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
9961,0491,0941,2531,3301,368
Upgrade
Market Cap Growth
-4.10%-4.10%-12.68%-5.77%-2.81%-2.36%
Upgrade
Enterprise Value
9901,0121,0261,2431,2071,307
Upgrade
Last Close Price
0.840.810.840.910.960.98
Upgrade
PE Ratio
8.158.5910.096.8715.6515.35
Upgrade
PS Ratio
6.647.008.065.7412.8012.44
Upgrade
PB Ratio
0.840.890.820.940.980.99
Upgrade
P/TBV Ratio
0.840.890.820.940.980.99
Upgrade
P/OCF Ratio
8.909.388.886.8013.7923.56
Upgrade
EV/Sales Ratio
6.606.757.565.7011.6211.88
Upgrade
EV/EBIT Ratio
8.118.299.466.8214.2114.67
Upgrade
Asset Turnover
0.120.120.100.160.080.08
Upgrade
Quick Ratio
2.092.099.795.3416.5120.60
Upgrade
Current Ratio
2.092.099.795.3416.5120.60
Upgrade
Return on Equity (ROE)
9.69%9.69%8.10%13.50%6.19%6.41%
Upgrade
Return on Assets (ROA)
5.97%5.97%4.98%8.33%3.85%3.96%
Upgrade
Return on Capital (ROIC)
6.05%6.05%5.06%8.44%3.87%4.00%
Upgrade
Return on Capital Employed (ROCE)
10.30%10.30%8.10%13.60%6.20%6.50%
Upgrade
Earnings Yield
12.27%11.64%9.91%14.55%6.39%6.51%
Upgrade
Dividend Yield
-8.61%8.33%7.69%7.29%7.12%
Upgrade
Payout Ratio
89.23%89.23%63.58%52.52%113.20%107.90%
Upgrade
Buyback Yield / Dilution
6.65%6.65%4.00%0.72%0.00%0.00%
Upgrade
Total Shareholder Return
6.65%15.26%12.34%8.41%7.29%7.12%
Upgrade
Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.